Use of Genomics to Track Coronavirus Disease Outbreaks, New Zealand.
2019 novel coronavirus disease
COVID-19
New Zealand
SARS-CoV-2
coronavirus disease
genomics
infectious disease
respiratory infections
severe acute respiratory syndrome coronavirus 2
viruses
zoonoses
Journal
Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155
Informations de publication
Date de publication:
05 2021
05 2021
Historique:
entrez:
26
4
2021
pubmed:
27
4
2021
medline:
22
6
2021
Statut:
ppublish
Résumé
Real-time genomic sequencing has played a major role in tracking the global spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), contributing greatly to disease mitigation strategies. In August 2020, after having eliminated the virus, New Zealand experienced a second outbreak. During that outbreak, New Zealand used genomic sequencing in a primary role, leading to a second elimination of the virus. We generated genomes from 78% of the laboratory-confirmed samples of SARS-CoV-2 from the second outbreak and compared them with the available global genomic data. Genomic sequencing rapidly identified that virus causing the second outbreak in New Zealand belonged to a single cluster, thus resulting from a single introduction. However, successful identification of the origin of this outbreak was impeded by substantial biases and gaps in global sequencing data. Access to a broader and more heterogenous sample of global genomic data would strengthen efforts to locate the source of any new outbreaks.
Identifiants
pubmed: 33900175
doi: 10.3201/eid2705.204579
pmc: PMC8084492
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1317-1322Références
Virus Evol. 2020 Apr 10;6(1):veaa027
pubmed: 32296544
Transbound Emerg Dis. 2020 Jul;67(4):1453-1462
pubmed: 32306500
Mol Biol Evol. 2013 Apr;30(4):772-80
pubmed: 23329690
Nucleic Acids Res. 2019 Jul 2;47(W1):W256-W259
pubmed: 30931475
Bioinformatics. 2018 Dec 1;34(23):4121-4123
pubmed: 29790939
Lancet Infect Dis. 2020 May;20(5):533-534
pubmed: 32087114
Lancet Infect Dis. 2020 Apr;20(4):400-402
pubmed: 32113509
Science. 2020 Oct 30;370(6516):571-575
pubmed: 32913002
Lancet Public Health. 2020 Nov;5(11):e612-e623
pubmed: 33065023
PLoS Comput Biol. 2019 Apr 8;15(4):e1006650
pubmed: 30958812
Biol Methods Protoc. 2020 Jul 18;5(1):bpaa014
pubmed: 33029559
Nat Med. 2020 Sep;26(9):1398-1404
pubmed: 32647358
Nat Commun. 2020 Dec 11;11(1):6351
pubmed: 33311501
Nat Med. 2020 Sep;26(9):1405-1410
pubmed: 32678356
Nat Nanotechnol. 2020 Aug;15(8):646-655
pubmed: 32669664
Science. 2020 Sep 4;369(6508):1255-1260
pubmed: 32703910
Mol Biol Evol. 2005 May;22(5):1185-92
pubmed: 15703244
Glob Chall. 2017 Jan 10;1(1):33-46
pubmed: 31565258
Nat Microbiol. 2020 Nov;5(11):1403-1407
pubmed: 32669681
PLoS Biol. 2020 Aug 21;18(8):e3000869
pubmed: 32822393